in fact now we are capitalizing as if the li-key covid vaccine was worth zero: in November of last year, GNBT capitalized 70 million, now, despite the increase in the number of shares in circulation, it capitalizes 26 million. But in the meantime, in addition to the aforementioned vaccine, other pieces have become part of the Generex world: how can we explain that we capitalize 1/3 of the pre-covid? Is the progress made over the past year worth nothing besides the vaccine?